Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashley Keller

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Chest|June 13, 2024
Sex Differences After Treatment With Ivacaftor in People With Cystic FibrosisMelanie Holtrop, Sophia Cosmich, MinJae Lee, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 23, 2024
Concentrations of dehydroepiandrosterone-sulphate (DHEA-S) in people with cystic fibrosis on and off elexacaftor-tezacaftor-ivacaftorShadaan Abid, Lauren Shaffer, Andrew Bayat, et al.
American Journal of Respiratory and Critical Care Medicine|May 10, 2018
Disparities in Mortality of Hispanic Patients with Cystic Fibrosis in the United States. A National and Regional Cohort StudyJason Rho, Chul Ahn, Ang Gao, et al.
Pediatric Pulmonology|July 10, 2026
Meaningful Criteria to Persons Living With Cystic Fibrosis and Their Healthcare Providers in Helping Determine Adjustments to Routine Clinical Follow-UpWilliam R Hunt, Christian Merlo, Ashley Keller, et al.
Annals of the American Thoracic Society|February 5, 2021
A Prospective Study of the Effects of Sex Hormones on Lung Function and Inflammation in Women with Cystic FibrosisMelanie Holtrop, Sonya Heltshe, Veronika Shabanova, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 27, 2023
Sex differences in outcomes of people with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftorAngela Wang, MinJae Lee, Ashley Keller, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|July 13, 2026
Intestinal Permeability Responses to Maximal and Submaximal Exercise in Individuals with Normal-Weight Obesity: An Exploratory StudyBryant H Keirns, Ashley Keller, Alexis R Quirk, et al.
International Journal of Environmental Research and Public Health|January 25, 2025
Influence of Sex and Body Composition on Aerobic Capacity in Normal Weight Lean, Normal Weight Obese, and Obese PhenotypesSam R Emerson, Samantha Hart, Christina M Sciarrillo, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 30, 2022
Evaluation of an association between RANKL and OPG with bone disease in people with cystic fibrosisShadaan Abid, MinJae Lee, Bailey Rodich, et al.
Infection and Drug Resistance|October 2, 2018
Multidrug-resistant <i>Pseudomonas aeruginosa</i> from sputum of patients with cystic fibrosis demonstrates a high rate of susceptibility to ceftazidime-avibactamStan D Atkin, Shadaan Abid, Michael Foster, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Chest|June 13, 2024
Sex Differences After Treatment With Ivacaftor in People With Cystic FibrosisMelanie Holtrop, Sophia Cosmich, MinJae Lee, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 23, 2024
Concentrations of dehydroepiandrosterone-sulphate (DHEA-S) in people with cystic fibrosis on and off elexacaftor-tezacaftor-ivacaftorShadaan Abid, Lauren Shaffer, Andrew Bayat, et al.
American Journal of Respiratory and Critical Care Medicine|May 10, 2018
Disparities in Mortality of Hispanic Patients with Cystic Fibrosis in the United States. A National and Regional Cohort StudyJason Rho, Chul Ahn, Ang Gao, et al.
Pediatric Pulmonology|July 10, 2026
Meaningful Criteria to Persons Living With Cystic Fibrosis and Their Healthcare Providers in Helping Determine Adjustments to Routine Clinical Follow-UpWilliam R Hunt, Christian Merlo, Ashley Keller, et al.
Annals of the American Thoracic Society|February 5, 2021
A Prospective Study of the Effects of Sex Hormones on Lung Function and Inflammation in Women with Cystic FibrosisMelanie Holtrop, Sonya Heltshe, Veronika Shabanova, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 27, 2023
Sex differences in outcomes of people with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftorAngela Wang, MinJae Lee, Ashley Keller, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|July 13, 2026
Intestinal Permeability Responses to Maximal and Submaximal Exercise in Individuals with Normal-Weight Obesity: An Exploratory StudyBryant H Keirns, Ashley Keller, Alexis R Quirk, et al.
International Journal of Environmental Research and Public Health|January 25, 2025
Influence of Sex and Body Composition on Aerobic Capacity in Normal Weight Lean, Normal Weight Obese, and Obese PhenotypesSam R Emerson, Samantha Hart, Christina M Sciarrillo, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 30, 2022
Evaluation of an association between RANKL and OPG with bone disease in people with cystic fibrosisShadaan Abid, MinJae Lee, Bailey Rodich, et al.
Infection and Drug Resistance|October 2, 2018
Multidrug-resistant <i>Pseudomonas aeruginosa</i> from sputum of patients with cystic fibrosis demonstrates a high rate of susceptibility to ceftazidime-avibactamStan D Atkin, Shadaan Abid, Michael Foster, et al.
Pageof 2